United States Senators Urge DOJ and FDA for E-cigarette Enforcement

Regulations by 2FIRSTS.ai
Jul.09.2024
United States Senators Urge DOJ and FDA for E-cigarette Enforcement
Senators Demand More Information on Crackdown on Unauthorized E-Cigarette Sales by Multi-Agency Task Force, Expressing Concerns Over Inconsistencies in Statements.

According to a report from the Sierra Sun Times on July 8th, last week, US Senator Susan Collins and her bipartisan colleagues wrote to senior officials at the Department of Justice (DOJ) Consumer Protection Division and the US Food and Drug Administration (FDA) Center for Tobacco Products, requesting more information about the recently announced interagency task force to combat unauthorized e-cigarette sales and distribution.

 

The letter also reiterated the importance of restoring the pre-market review process required by federal law. The letter was co-signed by Senators Dick Durbin (D-IL), Mitt Romney (R-UT), Richard Blumenthal (D-CT), Jeff Merkley (D-OR), Thom Tillis (R-NC), Mazie Hirono (D-HI), and Ron Wyden (D-OR).

 

The senators wrote,

 

We appreciate the recent announcement of the establishment of a federal task force to enhance enforcement of these illegal and dangerous products through the collaboration of the FDA, Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives, U.S. Marshals Service, U.S. Postal Inspection Service, and Federal Trade Commission. However, we remain deeply concerned about the inconsistency between the public statements of the FDA and DOJ, which claim that only 27 e-cigarette products have been authorized by the FDA, while in fact, thousands of unauthorized e-cigarettes with child-friendly flavors such as blueberry ice, strawberry watermelon bubblegum, and Red Bull strawberry are still readily available.

 

Clearly, the top priority of the working group should be to restore the pre-market review system for e-cigarettes and enforce the removal of all unauthorized e-cigarettes.

 

On June 10, 2024, the United States Department of Justice and the Food and Drug Administration announced the establishment of a federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes. In addition to the FDA and the DOJ, this task force will also bring together multiple law enforcement agencies, utilizing all criminal and civil measures to crack down on illegal e-cigarette distribution and sale.

 

This letter also calls on the FDA to complete long-term reviews of premarket tobacco product applications submitted by e-cigarette manufacturers. Since the FDA missed the final deadline set by the court on September 9, 2021, over 2.1 million children may have already started using e-cigarettes. The FDA also missed another deadline to complete reviews of certain products by June 30, 2024. According to the Tobacco Control Act (TCA), e-cigarette companies must obtain FDA authorization before entering the market, a requirement that the FDA has failed to enforce.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria reported Q3 2025 net revenue of $6.072 billion, a 3.0% year-on-year decline. Adjusted EPS increased 3.6% to $1.45. The company expanded its share repurchase program to $2 billion and launched the on!PLUS nicotine pouch in Florida, North Carolina, and Texas.
Oct.31 by 2FIRSTS.ai
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgium’s drug commissioner Ine Van Wymersch has warned that more than 80% of illegal refillable vape capsules seized in Belgium contain synthetic opioids, posing serious risks of early addiction among children. She told Euronews that these substances, which have no distinctive smell or color, could lead to opioid dependence from a young age.
Dec.08 by 2FIRSTS.ai
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian Duma considers comprehensive regulations to address widespread e-cigarette use among youth, including potential sales bans and flavor restrictions.
Oct.20 by 2FIRSTS.ai
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.
Nov.24 by 2FIRSTS.ai
Swedish Oral Pouch Manufacturer WiJo to Establish U.S. Production Base, Targeting March 2026 Start-Up
Swedish Oral Pouch Manufacturer WiJo to Establish U.S. Production Base, Targeting March 2026 Start-Up
Swedish oral pouch manufacturer WiJo Pouches has announced plans to establish its first North American production facility in South Carolina, where it will lease a manufacturing site to produce nicotine, caffeine and functional pouch products. The project, expected to begin operations in March 2026 and create about 170 jobs, has secured tax incentive support from both state and county authorities.
Dec.05 by 2FIRSTS.ai
California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case
California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case
U.S. District Judge William Orrick of the Northern District of California indicated on Friday that he will likely certify classes of direct and indirect purchasers accusing e-cigarette makers Juul Labs Inc. and former rival Altria Group Inc. of conspiring to limit product variety and violate antitrust laws.
Oct.20 by 2FIRSTS.ai